Project Q: Cue-based Treatment Intervention to Promote Cessation Among People Who Smoke Lightly or Non-daily
- Sponsor
- Duke University
- Study ID
- NCT07425119
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Tobacco Use Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Cognitive Behavioral Therapy (CBT) — BEHAVIORALCBT delivered via telehealth sessions and supportive text messages.
- Cue-based treatment intervention — BEHAVIORALCue-based treatment includes exposure to smoking-related cues and coping strategies.
Study Details
This study aims to test the feasibility and acceptability of a remotely delivered cue-based treatment intervention to promote smoking cessation among people who smoke lightly or non-daily. Secondary objectives include assessing preliminary efficacy on cessation and examining cue reactivity. Participants will be randomized to CBT only or CBT + cue-based treatment, with assessments at baseline, end-of-treatment, 6 months, and 12 months.
Key Dates
- First listed
- Feb 20, 2026
- Start date
- Jun 30, 2026
- Status verified
- Jun 2026
- Primary completion
- Jan 31, 2028
- Completion
- Jun 30, 2028
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: CBT onlyCBT delivered via telehealth sessions and supportive text messages.
- Experimental: CBT + Cue-based treatmentCBT plus cue-based treatment includes exposure to smoking-related cues and coping strategies.
Primary Outcome Measure
Feasibility as measured by the number of participants who are recruited and randomized [ Time Frame: During the recruitment period (up to 9 months) ]
Central Contacts
- Laura Fish, PhD919-681-3820
- Lauren Hart, MSW, MPH919-613-2607
Related Studies
- An fMRI Study of the Effects of Clavulanic Acid on Drug AddictionPHASE2 · Recruiting · University of Missouri-Columbia · Columbia, Missouri
- Smoking Cessation Behavioral Treatment StudyRecruiting · University of Missouri-Columbia · Columbia, Missouri
- Oral Cannabidiol for Tobacco CessationPHASE1 · Recruiting · Johns Hopkins University · Baltimore, Maryland
- 5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use DisorderPHASE2 · Recruiting · Johns Hopkins University · Birmingham, Alabama